Several authors reported hemostatic alterations in vWF/ADAMTS13 axis that were strongly associated with disease severity in COVID-19 patients, including increased levels of vWF [61,62,63,64] accompanied by low normal or mildly decreased ADAMTS13 activity [65,66,67,68,69,70]. The gene discussed is VWF; the disease is COVID-19.